ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Dana-Farber Cancer Institute and Deerfield Management, a life sciences investment firm, have formed Riverway Discoveries to develop diagnostics and drugs for cancer. Deerfield has invested in research at several universities in recent years and formed its first partnership with Dana-Farber in 2018, when it promised to bankroll up to $80 million of research on small-molecule protein degraders. Through Riverway, Deerfield will spend up to $130 million over 10 years on translational research projects proposed by Dana-Farber scientists and assessed by a joint steering committee.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X